ADCT vs BIIB: Which Stock is Better?
Side-by-side comparison of Adc Therapeutics Sa and Biogen Inc in 2026
ADCT
Adc Therapeutics Sa
$4.11
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ADCT | BIIB | Winner |
|---|---|---|---|
| Market Cap | $509.13M | $27.13B | BIIB |
| P/E Ratio | N/A | 21.42 | BIIB |
| EPS (TTM) | $N/A | $8.63 | BIIB |
| Revenue Growth | -0.1% | -0.1% | BIIB |
| Gross Margin | -57.4% | 78.9% | BIIB |
Analyze ADCT
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ADCT or BIIB a better investment?
Comparing ADCT and BIIB: Adc Therapeutics Sa has a market cap of $509.13M while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ADCT and BIIB?
ADCT (Adc Therapeutics Sa) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ADCT or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ADCT or BIIB?
BIIB has higher revenue growth at -0.1% vs -0.1% for ADCT.
Which company is more profitable: ADCT or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to -57.4% for ADCT.
Which is the larger company: ADCT or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $509.13M for ADCT.
Should I buy ADCT or BIIB in 2026?
Both ADCT and BIIB have investment merit. ADCT trades at $4.11 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ADCT and BIIB stock?
Key differences: Market Cap ($509.13M vs $27.13B), P/E Ratio (N/A vs 21.4x), Revenue Growth (-0.1% vs -0.1%), Gross Margin (-57.4% vs 78.9%).